spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits

The exciting new finding that spironolactone (Aldactone) is beneficial for heart failure will change prescribing habits.

Researchers saw such significant improvement that they stopped the study early. The New England Journal of Medicine released the article over a month before it was scheduled to be published.

Adding spironolactone to the usual therapy for severe CHF improves symptoms...and reduces mortality and hospitalization by 30%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote